Shire PLC (NASDAQ:SHPG) – Stock analysts at William Blair decreased their FY2019 earnings estimates for shares of Shire PLC in a research report issued to clients and investors on Monday. William Blair analyst T. Lugo now expects that the biopharmaceutical company will post earnings per share of $18.17 for the year, down from their prior estimate of $18.27. William Blair also issued estimates for Shire PLC’s FY2020 earnings at $19.62 EPS.
SHPG has been the subject of several other research reports. BidaskClub lowered Shire PLC from a “sell” rating to a “strong sell” rating in a report on Wednesday, July 19th. Barclays PLC lowered Shire PLC from an “overweight” rating to an “equal weight” rating in a report on Friday, August 11th. Evercore ISI assumed coverage on Shire PLC in a report on Wednesday, August 16th. They set an “outperform” rating and a $196.00 price target for the company. Cantor Fitzgerald set a $222.00 price target on Shire PLC and gave the company a “buy” rating in a report on Saturday, July 1st. Finally, Royal Bank Of Canada reissued a “buy” rating and set a $213.00 price target on shares of Shire PLC in a report on Monday, October 2nd. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and thirteen have issued a buy rating to the company. Shire PLC presently has a consensus rating of “Buy” and an average target price of $220.91.
COPYRIGHT VIOLATION NOTICE: This report was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this report on another domain, it was copied illegally and republished in violation of US & international trademark and copyright laws. The legal version of this report can be accessed at https://www.dispatchtribunal.com/2017/10/27/shire-plc-to-post-fy2019-earnings-of-18-17-per-share-william-blair-forecasts-shpg.html.
Shire PLC (NASDAQ:SHPG
) traded down 3.3013% on Wednesday, hitting $147.0304. The stock had a trading volume of 1,658,332 shares. Shire PLC has a 52 week low of $139.36 and a 52 week high of $192.64.
Shire PLC (NASDAQ:SHPG) last posted its quarterly earnings results on Friday, October 27th. The biopharmaceutical company reported $3.37 earnings per share for the quarter, missing the consensus estimate of $3.66 by ($0.29). Shire PLC had a return on equity of 14.10% and a net margin of 4.70%.
Several institutional investors have recently made changes to their positions in the company. Inspirion Wealth Advisors LLC lifted its position in shares of Shire PLC by 0.4% in the second quarter. Inspirion Wealth Advisors LLC now owns 1,944 shares of the biopharmaceutical company’s stock valued at $321,000 after acquiring an additional 8 shares in the last quarter. Synovus Financial Corp lifted its position in shares of Shire PLC by 0.4% in the second quarter. Synovus Financial Corp now owns 2,780 shares of the biopharmaceutical company’s stock valued at $458,000 after acquiring an additional 11 shares in the last quarter. Baldwin Investment Management LLC lifted its position in shares of Shire PLC by 1.4% in the second quarter. Baldwin Investment Management LLC now owns 1,626 shares of the biopharmaceutical company’s stock valued at $269,000 after acquiring an additional 23 shares in the last quarter. Hartford Financial Management Inc. lifted its position in shares of Shire PLC by 5.4% in the second quarter. Hartford Financial Management Inc. now owns 621 shares of the biopharmaceutical company’s stock valued at $102,000 after acquiring an additional 32 shares in the last quarter. Finally, American International Group Inc. lifted its position in shares of Shire PLC by 1.2% in the first quarter. American International Group Inc. now owns 4,607 shares of the biopharmaceutical company’s stock valued at $803,000 after acquiring an additional 54 shares in the last quarter. Institutional investors and hedge funds own 19.24% of the company’s stock.
The firm also recently disclosed a semiannual dividend, which will be paid on Friday, October 20th. Stockholders of record on Friday, September 8th will be given a $0.1527 dividend. The ex-dividend date of this dividend is Thursday, September 7th. This represents a dividend yield of 0.21%. Shire PLC’s payout ratio is 41.07%.
Shire PLC Company Profile
Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.
Receive News & Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related companies with MarketBeat.com's FREE daily email newsletter.